cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.29209644.v1
title: Patient, caregiver experiences in metastatic castration-resistant prostate cancer: insights from a multi-national survey

description: Patients with metastatic castration-resistant prostate cancer (mCRPC) and caregivers were surveyed to understand their attitudes, emotions, and experiences with the disease, its treatments, and their willingness to explore genetic testing. A non-interventional, cross-sectional, online, quantitative-qualitative survey was conducted from 17-February to 9March 2022 among patients (≥21-years old) with mCRPC (diagnosis for ≥3-months) and caregivers. A total of 221 patients with mCRPC and 159 caregivers from USA, France, Germany, Canada, Spain, China, and Brazil were surveyed. mCRPC impacts mood, emotional and mental health (50–77%), sleep (48–68%), career goals (48–80%), and social activities (46–65%). Primary symptoms/side effects are urination issues (trouble urinating: 33–60%; painful/burning urination: 32–50%, frequent urination: 27–50%) and sexual dysfunction (lower libido: 10–57%), which impact romantic relationships. Caregivers often spouses or partners, provide practical, financial, and emotional support, averaging 11 hours/week of providing care. Patients face high treatment and pill burden (7–12 pills/day) and prefer simpler treatment regimens. Hope motivates patients and genetic testing is one such avenue of hope. mCRPC is a life-changing diagnosis with physical, psychological, and financial burdens. By encouraging early genetic testing and fostering patient-centered conversation, HCPs can provide personalized care for optimized treatment outcomes in mCRPC. This study assessed the experiences of people living with metastatic castration-resistant prostate cancer (mCRPC) – a type of advanced prostate cancer that may not respond to certain treatments – and the caregivers who support such individuals. Researchers surveyed patients and caregivers in seven countries to better understand how mCRPC affects daily life and how they feel about treatments and genetic testing. The results showed that mCRPC has a major impact on many areas of life, including mood, mental health, sleep, career goals, and social activities. Common symptoms include problems with urination and trouble with sex, which also affect romantic relationships. Most caregivers were spouses or partners who provided both emotional and financial support, spending an average of 11 hours each week helping their loved ones. Patients take many pills daily and generally prefer simpler treatment routines. Despite the challenges, many patients remain hopeful, and some see genetic testing as a promising option for more personalized treatment. In conclusion, mCRPC affects physical health, mental well-being and finances of both patients and caregivers. Encouraging early genetic testing and supportive conversations between patients and healthcare providers may lead to better treatment experiences and outcomes.
DOI: 10.6084/m9.figshare.29263994
title: J-REGISTER: real-world study of Japanese patients with <i>EGFR</i> mutation-positive NSCLC treated with first-line afatinib

description: The J-REGISTER study assessed outcomes and subsequent treatment in patients with <i>EGFR</i> mutation-positive NSCLC treated with first-line afatinib, including patients with uncommon <i>EGFR</i> mutations. This retrospective study assessed 805 patients treated with afatinib in Japan. The primary objective was time on treatment with afatinib. Other objectives included time on treatment from initiation of afatinib until the end of second-line therapy, and overall survival. Median time on treatment with afatinib was 13.4 months (14.3/10.1 months in patients with common/uncommon mutations). Median overall time on treatment was highest in patients who received sequential afatinib and osimertinib (32.8 months). Median overall survival was 41.2 months. Afatinib is an effective first-line treatment option for Japanese patients with <i>EGFR</i> mutation-positive NSCLC. NCT04795245. This study describes treatment patterns in patients with a type of lung cancer that is caused by a mutation in a gene called the epidermal growth factor receptor (<i>EGFR</i>). Many kinds of <i>EGFR</i> mutations have been identified and are grouped as “common” or “uncommon” mutations. Patients with <i>EGFR</i> mutation-positive cancer are usually treated with tablets called EGFR tyrosine kinase inhibitors (TKIs), which are very effective at silencing abnormal forms of EGFR that drive tumor growth. Unfortunately, tumors may eventually become resistant to EGFR TKIs and alternative treatments are required (named “second-line treatments”). There are several types of EGFR TKI available: first-generation (e.g. gefitinib, erlotinib); second-generation (e.g. afatinib, dacomitinib) and third-generation (osimertinib) TKIs. A few unanswered questions remain regarding the optimal use of EGFR TKIs. Firstly, which EGFR TKI is most effective against uncommon <i>EGFR</i> mutations and, secondly, what is the most effective second-line treatment after first-line treatment with an EGFR TKI? In this study, we reviewed treatment patterns in 805 patients with lung cancer in Japan who received afatinib. We found that half of patients remained on treatment for at least 13 months, providing further evidence that afatinib is an effective therapy. Afatinib was effective in patients with uncommon and common <i>EGFR</i> mutations. The most common second-line treatment after afatinib was chemotherapy. Approximately a third of patients received another EGFR TKI after afatinib, most commonly osimertinib, which was the most effective second-line treatment. Sequential afatinib and osimertinib treatment should be considered. In a real-world study in 805 Japanese patients with<i>EGFR</i> mutation-positive NSCLC treated with first-line afatinib, afatinib appeared to be effective in patients with common and uncommon <i>EGFR</i> mutations. The most effective subsequent treatment option was osimertinib.
DOI: 10.6084/m9.figshare.29263994.v1
title: J-REGISTER: real-world study of Japanese patients with <i>EGFR</i> mutation-positive NSCLC treated with first-line afatinib

description: The J-REGISTER study assessed outcomes and subsequent treatment in patients with <i>EGFR</i> mutation-positive NSCLC treated with first-line afatinib, including patients with uncommon <i>EGFR</i> mutations. This retrospective study assessed 805 patients treated with afatinib in Japan. The primary objective was time on treatment with afatinib. Other objectives included time on treatment from initiation of afatinib until the end of second-line therapy, and overall survival. Median time on treatment with afatinib was 13.4 months (14.3/10.1 months in patients with common/uncommon mutations). Median overall time on treatment was highest in patients who received sequential afatinib and osimertinib (32.8 months). Median overall survival was 41.2 months. Afatinib is an effective first-line treatment option for Japanese patients with <i>EGFR</i> mutation-positive NSCLC. NCT04795245. This study describes treatment patterns in patients with a type of lung cancer that is caused by a mutation in a gene called the epidermal growth factor receptor (<i>EGFR</i>). Many kinds of <i>EGFR</i> mutations have been identified and are grouped as “common” or “uncommon” mutations. Patients with <i>EGFR</i> mutation-positive cancer are usually treated with tablets called EGFR tyrosine kinase inhibitors (TKIs), which are very effective at silencing abnormal forms of EGFR that drive tumor growth. Unfortunately, tumors may eventually become resistant to EGFR TKIs and alternative treatments are required (named “second-line treatments”). There are several types of EGFR TKI available: first-generation (e.g. gefitinib, erlotinib); second-generation (e.g. afatinib, dacomitinib) and third-generation (osimertinib) TKIs. A few unanswered questions remain regarding the optimal use of EGFR TKIs. Firstly, which EGFR TKI is most effective against uncommon <i>EGFR</i> mutations and, secondly, what is the most effective second-line treatment after first-line treatment with an EGFR TKI? In this study, we reviewed treatment patterns in 805 patients with lung cancer in Japan who received afatinib. We found that half of patients remained on treatment for at least 13 months, providing further evidence that afatinib is an effective therapy. Afatinib was effective in patients with uncommon and common <i>EGFR</i> mutations. The most common second-line treatment after afatinib was chemotherapy. Approximately a third of patients received another EGFR TKI after afatinib, most commonly osimertinib, which was the most effective second-line treatment. Sequential afatinib and osimertinib treatment should be considered. In a real-world study in 805 Japanese patients with<i>EGFR</i> mutation-positive NSCLC treated with first-line afatinib, afatinib appeared to be effective in patients with common and uncommon <i>EGFR</i> mutations. The most effective subsequent treatment option was osimertinib.
DOI: 10.15468/dl.ndt2nz
title: Occurrence Download

description: A dataset containing 16218 species occurrences available in GBIF matching the query:
{
 "and" : [
 "GadmGid is one of (USA.41_1, USA.34_1, USA.11_1)",
 "TaxonKey is Odocoileus virginianus"
 ]
}

 The dataset includes 16218 records from 18 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031052-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.17601090
title: Data for "Revisiting thermal transport in CuCl: First-principles calculations and machine learning force fields"

description: The dataset includes thermally displaced atomic positions generated using the quantum canonical distribution with the TDEP package, along with the corresponding calculated forces, both with and without lattice thermal expansion (TE). The ML_AB file, containing the accumulated training data for the VASP on-the-fly machine learning force field, is also included.
DOI: 10.5281/zenodo.17601091
title: Data for "Revisiting thermal transport in CuCl: First-principles calculations and machine learning force fields"

description: The dataset includes thermally displaced atomic positions generated using the quantum canonical distribution with the TDEP package, along with the corresponding calculated forces, both with and without lattice thermal expansion (TE). The ML_AB file, containing the accumulated training data for the VASP on-the-fly machine learning force field, is also included.
DOI: 10.15468/dl.8tuw7b
title: Occurrence Download

description: A dataset containing 8261 species occurrences available in GBIF matching the query:
{
 "and" : [
 "OccurrenceStatus is Present",
 "TaxonKey is Pituophis melanoleucus"
 ]
}

 The dataset includes 8261 records from 111 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031051-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.9zdjs4
title: Occurrence Download

description: A dataset containing 7632 species occurrences available in GBIF matching the query:
{
 "and" : [
 "GadmGid is one of (USA.41_1, USA.18_1, USA.43_1, USA.11_1, USA.34_1)",
 "TaxonKey is Agkistrodon contortrix"
 ]
}

 The dataset includes 7632 records from 36 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031053-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ygpqbq
title: Occurrence Download

description: A dataset containing 2096 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((25.6578 -34.0342,58.80572 -34.0342,58.80572 0.33103,25.6578 0.33103,25.6578 -34.0342))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Stenella"
 ]
}

 The dataset includes 2096 records from 43 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031056-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.17578086
title: A Global Analysis of Traditional Diet Share and Diabetes Prevalence: Quantifying the Protective Role of Cultural Food Heritage (2000–2023)

description: Traditional dietary patterns, reflecting centuries of cultural adaptation and culinary wisdom, are increasingly being displaced by industrialized foods worldwide. This interdisciplinary study bridges ethnographic insight with population-level statistics to quantify the share of traditional foods in national diets and examine their association with diabetes prevalence from 2000 to 2023.

Using FAO Food Balance Sheets merged with World Bank indicators for GDP, education, and health, we generated 2,324 country–year observations. FAO food items were classified into twelve cultural food categories representing both traditional and modern systems. Two indices were developed: the Traditional Diet Index (TDI) the proportion of daily calories derived from cereals, pulses, roots/tubers, vegetables, and fruits   and the Dietary Diversity Index (DDI), based on Shannon entropy.

Ordinary least squares regression revealed a significant negative association between TDI and diabetes prevalence (β = −9.37, p = 0.006), after adjusting for income and education. Countries maintaining higher shares of traditional foods exhibited lower national diabetes rates.

These findings provide robust cross-national evidence that preserving traditional food heritage is not only a cultural imperative but also a vital public health strategy for combating diabetes underscoring the critical link between culinary tradition and population well-being. The TDI framework also provides a replicable model for future cross-cultural nutrition research.
DOI: 10.15468/dl.42x8wc
title: Occurrence Download

description: A dataset containing 770 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Acmaeoderella perroti"
 ]
}

 The dataset includes 770 records from 43 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031058-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.udw3q6
title: Occurrence Download

description: A dataset containing 19825 species occurrences available in GBIF matching the query:
{
 "and" : [
 "GadmGid is USA.41_1",
 "Geometry POLYGON((-81.69664 33.9444,-81.10064 33.94059,-81.14348 34.16243,-81.66617 34.1529,-81.70235 34.16243,-81.69664 33.9444))",
 "TaxonKey is Thryothorus ludovicianus"
 ]
}

 The dataset includes 19825 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031057-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.zthy8g
title: Occurrence Download

description: A dataset containing 73798 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Neogobius melanostomus"
 ]
}

 The dataset includes 73798 records from 182 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0030990-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.7ne4mp
title: Occurrence Download

description: A dataset containing 77 species occurrences available in GBIF matching the query:
{
 "and" : [
 "GadmGid is one of (USA.41_1, USA.34_1, USA.11_1, USA.47_1)",
 "TaxonKey is Canis rufus"
 ]
}

 The dataset includes 77 records from 3 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031060-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.yfcy7w
title: Occurrence Download

description: A dataset containing 11494 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is United States of America",
 "GadmGid is one of (USA.41_1, USA.11_1, USA.10_1, USA.34_1, USA.1_1, USA.47_1)",
 "TaxonKey is Chelydra serpentina"
 ]
}

 The dataset includes 11494 records from 44 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031059-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.92hswr
title: Occurrence Download

description: A dataset containing 100 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Hylodes cardosoi"
 ]
}

 The dataset includes 100 records from 6 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031061-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.17592681
title: Polyene hyphal lysis inhibits transmembrane potentials in MEA electrophysiology of mycelial biofilms

description: Replication data for paper entitled: "Polyene hyphal lysis inhibits transmembrane potentials in MEA electrophysiology of mycelial biofilms"

The uploaded data includes a single triplicate of mycelial biofilm wild-type controls (recording_he_biofilm_1_first_800s.bin)  and the polyene nystatin assay (recording_nystatin_assay_3_first_800s.bin).
DOI: 10.18150/h7wpii
title: Ekologiczny nanopłyn do chłodnic samochodowych o innowacyjnych parametrach użytkowych

description: Wykaz otwartych danych otrzymanych w ramach projektu POIR.01.02.00-00-0031/17 o nazwie "Ekologiczny nanopłyn do chłodnic samochodowych o innowacyjnych parametrach użytkowych"Zestaw danych obejmuje surowe dane uzystkane w latach 2018–2022. Udostępnione pliki zawierają wyniki badań fizykochemicznych, korozyjnych, termicznych oraz stabilnościowych dla otrzymanych wariantów formulacji płynów bazowych i nanofluidów zawierających różne formy nanomateriałów (m.in. nanorurki węglowe MWCNT, nanocząstki miedzi Cu@SiO₂, Cu/EL, Cu/GLIC).Zebrane dane obejmują:Parametry fizykochemiczne: pH, gęstość, refrakcję, temperatury krystalizacji, wrzenia i zapłonu, zawartość wody, rezerwę alkaliczną.Analizy materiałowe: obrazy TEM/SEM, charakterystykę nanocząstek i ich rozmiarów.Badania stabilności dyspergowanej fazy nano w różnych bazach glikolowych i z różnymi surfaktantami (PVP, P84, P127, Tween80).Wyniki korozji i elektrochemii: korozja w szkle, badania potencjodynamiczne, polaryzacja liniowa, impedancja.Analizy reologiczne i lepkościowe oraz dane przewodnictwa cieplnego baz i nanofluidów.Parametry procesów sonikacji dla wielu kombinacji stężeń stabilizatora i MWCNT, wraz z energią, czasem, temperaturą i efektem dyspersji.Porównania stabilności w czasie dla wielu typów nanomateriałów.Wyniki prób w skali 1/2-technicznej.Dane w plikach reprezentują cykl od wczesnych badań laboratoryjnych, przez optymalizację składu i procesów technologicznych, aż po próby przedskalowania.
DOI: 10.34740/kaggle/dsv/13720315
title: Peer-to-Peer Boliviano (BOB) Exchange Data
DOI: 10.15468/dl.h3euf4
title: Occurrence Download

description: A dataset containing 1809 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is Africa",
 "DatasetKey is one of (iNaturalist Research-grade Observations, Observation.org, Nature data from around the World)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "PublishingOrg is 28eb1a3f-1c15-4a95-931a-4af90ecb574d",
 "TaxonKey is Papio anubis",
 "Year 2022-2025"
 ]
}

 The dataset includes 1809 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031064-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.8ru84w
title: Occurrence Download

description: A dataset containing 25478 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Meetnetten.be - Bat winter roosts counts (totals per site) Flanders, Belgium"
 ]
}

 The dataset includes 25478 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0031063-251025141854904/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.17601292
title: Enhance financial inclusion in Uzbekistan

description:  Financial inclusion plays a crucial role in promoting economic growth, particularly in developing countries like Uzbekistan, where a significant portion of the population is still financially excluded. This paper explores the current state of financial inclusion and how to enhance it in Uzbekistan, the study takes key factors such as banking penetration, access to credit, mobile banking usage, and financial literacy. The study uses qualitative and quantitative methods, primarily employing trend analysis to track changes in these indicators over time. Data was gathered from reputable sources, including the National Statistical Committee of Uzbekistan, the Ministry of Finance, the Central Bank, the World Bank, and the IMF. The qualitative analysis identifies barriers to financial inclusion, including gaps in financial literacy, infrastructure constraints, and regulatory challenges. Furthermore, the study evaluates government initiatives, such as the National Strategy for Financial Inclusion (2023–2025), and their impact on expanding access to financial services. The findings suggest that, despite progress, significant challenges remain in reaching underserved populations, particularly in rural areas. The paper concludes that addressing these barriers through technological advancements, policy reforms, and enhanced collaboration between the government, financial institutions, and NGOs could foster more inclusive financial services and contribute to long-term economic development.
DOI: 10.5281/zenodo.17601291
title: Enhance financial inclusion in Uzbekistan

description:  Financial inclusion plays a crucial role in promoting economic growth, particularly in developing countries like Uzbekistan, where a significant portion of the population is still financially excluded. This paper explores the current state of financial inclusion and how to enhance it in Uzbekistan, the study takes key factors such as banking penetration, access to credit, mobile banking usage, and financial literacy. The study uses qualitative and quantitative methods, primarily employing trend analysis to track changes in these indicators over time. Data was gathered from reputable sources, including the National Statistical Committee of Uzbekistan, the Ministry of Finance, the Central Bank, the World Bank, and the IMF. The qualitative analysis identifies barriers to financial inclusion, including gaps in financial literacy, infrastructure constraints, and regulatory challenges. Furthermore, the study evaluates government initiatives, such as the National Strategy for Financial Inclusion (2023–2025), and their impact on expanding access to financial services. The findings suggest that, despite progress, significant challenges remain in reaching underserved populations, particularly in rural areas. The paper concludes that addressing these barriers through technological advancements, policy reforms, and enhanced collaboration between the government, financial institutions, and NGOs could foster more inclusive financial services and contribute to long-term economic development.